Connecta Therapeutics, the CRG and the IMIM join forces to develop an innovative treatment for fragile X syndrome
Barcelona The public-private consortium has obtained a grant of €1.97 million from the Spanish National Innovation Agency Preclinical studies have shown that the CTH120 molecule can modulate neuroplasticity, the ability of cells of the nervous system to regenerate in response to pathological influences The public-private consortium formed by...
Continue reading